Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-1 and CPP32, in Alzheimer's disease

Brain Research

Volumn 780, Issue 2, 1998, Pages 260-269

  Kitamura, Yoshihisa ^a   Shimohama, Shun ^b   Kamoshima, Wataru ^a   Ota, Takashi ^a   Matsuoka, Yasuji ^a   Nomura, Yasuyuki ^c   Smith, Mark A ^d   Perry, George ^d   Whitehouse, Peter J ^d   Taniguchi, Takashi ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c Faculty of Pharmaceutical Sciences   (Japan)

^d UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Alzheimer's disease; Bcl 2 family; Caspase family; Hippocampus; Human neuroblastoma cell line SH SY5Y; Temporal cortex

Indexed keywords

CASPASE; CASPASE 3; GENE PRODUCT; ICH 1; PROTEIN; PROTEIN BAD; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; B CELL LEUKEMIA; CELL LINE; CELL LOSS; CONTROLLED STUDY; CYTOSOL; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MEMBRANE; NERVE CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN FAMILY; TEMPORAL CORTEX;

EID: 0032509773     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)01202-X     Document Type: Article

References (68)

1. Anderson A.J., Su J.H., Cotman C.W. DNA damage and apoptosis in Alzheimer's disease: Colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay. J. Neurosci. 16:1996;1710-1719.
2. Behl C., Davis J.B., Klier F.G., Schbert D. Amyloid β peptide induces necrosis rather than apoptosis. Brain Res. 645:1994;253-264.
3. Behl C., Davis J.B., Lesley R., Schubert D. Hydrogen peroxide mediates amyloid β protein toxicity. Cell. 77:1994;817-827.
4. Bothmer J., Jolles J. Phosphoinositide metabolism, aging and Alzheimer's disease. Biochim. Biophys. Acta. 1225:1994;111-124.
5. Bowen D.M., Allen S.J., Benton J.S., Goodhardt M.J., Haan E.A., Palmer A.N., Sims N.R., Smith C.C.T., Spillane J.A., Esiri M.M., Neary D., Snowdon J.S., Wilcock G.K., Davison A.N. Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease. J. Neurochem. 41:1983;266-272.
6. Bradford M.M. Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
7. Busciglio J., Yankner B.A. Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature. 378:1995;776-779.
8. Coleman P.D., Flood D.G. Neuron numbers and dendritic extent in normal ageing and Alzheimer's disease. Neurobiol. Aging. 8:1987;521-545.
9. Cras P., Smith M.A., Richey P.L., Siedlak S.L., Mulvihill P., Perry G. Extracellular neurofibrillary tangles reflect neuronal loss and provide further evidence of extensive protein cross-linking in Alzheimer disease. Acta Neurophathol. 89:1995;291-295.
10. Davies A.M. The Bcl-2 family of proteins, and the regulation of neuronal survival. Trends Neurosci. 18:1995;355-358.
11. L is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis. Cancer Res. 55:1995;2576-2582.
12. Drache B., Diehl G.E., Beyreuther K., Perlmutter L.S., König G. Bcl-xl-specific antibody labels acted microglia associated with Alzheimer's disease and other pathological states. J. Neurosci. Res. 47:1997;98-108.
13. Dragunow M., Faull R.L.M., Lawlor P., Beilharz E.J., Singleton K., Walker E.B., Mee E. In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes. NeuroReport. 6:1995;1053-1057.
14. Enari M., Talanian R.V., Wong W.W., Nagata S. Sequential activation of ICE-like and CPP-like proteases during Fas-mediated apoptosis. Nature. 380:1996;723-726.
15. Farrow S.N., White J.H.M., Martinou I., Raven T., Pun K.-T., Grinham C.J., Martinou J.-C., Brown R. Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K. Nature. 374:1995;731-733.
16. Garcia I., Maetinou I., Tsujimoto Y., Martinou J.-C. Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene. Science. 258:1992;302-304.
17. González-García M., García I., Ding L., O'shea S., Boise L.H., Thompson C.B., Núñez G. Bcl-x is expressed in embryonic and postnatal neural tissues and functions to prevent neuronal cell death. Proc. Natl. Acad. Sci. USA. 92:1995;4304-4308.
18. Good P.F., Werner P., Hsu A., Olanow C.W., Perl D.P. Evidence for neuronal oxidative damage in Alzheimer's disease. Am. J. Pathol. 149:1996;21-28.
19. Hockanbery D.M., Oltivai Z.N., Yin X.-M., Milliman C.L., Korsmeyer S.J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell. 75:1993;241-251.
20. Itano Y., Ito A., Uehara T., Nomura Y. Regulation of Bcl-2 protein expression in human neuroblastoma SH-SY5Y cells: Positive and negative effects of protein kinases C and A, respectively. J. Neurochem. 67:1996;131-137.
21. Kane D.J., Sarafian T.A., Anton R., Hahn H., Gralla E.B., Valentine J.S., Örd T., Bredesen D.E. Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science. 262:1993;1274-1277.
22. Katzman R. Alzheimer's disease. New Engl. J. Med. 314:1986;964-973.
23. Kiefer M.C., Brauer M.J., Powers V.C., Wu J.J., Umansky S.R., Tomei L.D., Barr P.J. Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature. 374:1995;736-739.
24. Krajewski S., Krajewska M., Shabaik A., Wang H.-G., Irie S., Fong L., Reed J.C. Immunohistochemical analysis of in vivo patterns of Bcl-X expression. Cancer Res. 54:1994;5501-5507.
25. Krajewski S., Krajewska M., Reed J.C. Immunohistochemical analysis of in vivo patterns of Bak expression, a proapoptotic member of the Bcl-2 protein family. Cancer Res. 56:1996;2849-2855.
26. Kumar S. ICE-like proteases in apoptosis. Trends Biochem. Sci. 20:1995;198-202.
27. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
28. LaFerla F.M., Tinkle B.T., Bieberich C.J., Haudenschild C.C., Jay G. The Alzheimer's Aβ peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Nature Genetics. 9:1995;21-30.
29. Lassmann H., Bancher C., Breitschopf H., Wegiel J., Bobinski M., Jellinger K., Wisniewski H.M. Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathol. 89:1995;35-41.
30. Li Y.-P., Bushnell A.F., Lee C.-M., Perlmutter L.S., Wong S.K.-F. β-Amyloid induces apoptosis in human-derived neurotypic SH-SY5Y cells. Brain Res. 738:1996;196-204.
31. Loo D.T., Copani A., Pike C.J., Whittemore E.D., Walencewicz A.J., Cotman C.W. Apoptosis is induced by β-amyloid in cultured central nervous system neurons. Proc. Natl. Acad. Sci. USA. 90:1993;7951-7955.
32. Martinou J.-C., Dubois-Dauphin M., Staple J.K., Rodriguez I., Frankowski H., Missotten M., Albertini P., Talabot D., Catsicas S., Pietra C., Huarte J. Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron. 13:1994;1017-1030.
33. Masliah E., Cole G., Shimohama S., Hansen L., DeTeresa R., Terry R.D., Saitoh T. Differential involvement of protein kinase C isozymes in Alzheimer's disease. J. Neurosci. 10:1990;2113-2124.
34. Mirra S.S., Heyman A., Mckeel D., Sumi S.M., Crain B.J., Brownlee L.M., Vogel F.S., Hughes J.P., van Belle G., Berg L. The consortium to establish a registry for Alzheimer's disease (CERAD): Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 41:1991;479-486.
35. Motoyama N., Wang F., Roth K.A., Sawa H., Nakayama K., Nakayama K., Negishi I., Senju S., Zhang Q., Fujii S., Loh D.Y. Massive cell death of immature hematopoietic cells and neurons in Bcl-X-deficient mice. Science. 267:1995;1506-1510.
36. 3H]TCP) binding in human frontal cortex: decreases in Alzheimer-type dementia. J. Neurochem. 54:1990;526-532.
37. O'Barr S., Schultz J., Rogers J. Expression of the protooncogene bcl-2 in Alzheimer's disease brain. Neurobiol. Aging. 17:1996;131-136.
38. Ohm T.G., Bohl J., Lemmer B. Reduced basal and stimulated (isoprenaline, Gpp(NH)p, forskolin) adenylate cyclase activity in Alzheimer's disease correlated with histopathological changes. Brain Res. 540:1991;229-236.
39. Oltvai Z.N., Milliman C.L., Korsmeyer S.J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 74:1993;609-619.
40. O'Neill C.J., Winblad W.B., Cowburn R.F. Neurotransmitter, receptor and signal transduction disturbances in Alzheimer's disease. Acta Neurol. Scand. Suppl. 139:1992;59-62.
41. Prehn J.H.M., Bindokas V.P., Jordán J., Galindo M.F., Ghade G.D., Roos R.P., Boise L.H., Thompson C.B., Krajewski S., Reed J.C., Miller R.J. Protective effect of transforming growth factor-β-1 on β-amyloid neurotoxicity in rat hippocampus. Mol. Pharmacol. 49:1996;319-328.
42. Posmantur R., McGinnis K., Nadimpalli R., Gilbertsen R.B., Wang K.K.W. Characterization of CPP32-like protease activity following apoptotic challenge in SH-SY5Y neuroblastoma cells. J. Neurochem. 68:1997;2328-2337.
43. Reed J.C. Double identity for proteins of the Bcl-2 family. Nature. 387:1997;773-776.
44. Reed J.C., Meister L., Tanaka S., Cuddy M., Yum S., Geyer C., Pleasure D. Differential expression of bcl-2 protooncogene in neuroblastoma and other human tumor cell lines of neural origin. Cancer Res. 51:1991;6529-6538.
45. Ross R.A., Spengler B.A., Biedler J.L. Coordinate morphological and biochemical interconversion of human neuroblastoma cells. J. Natl. Cancer Inst. 71:1983;741-747.
46. Satou T., Cummings B.J., Cotman C.W. Immunoreactivity for Bcl-2 protein within neurons in the Alzheimer's disease brain increases with disease severity. Brain Res. 697:1995;35-43.
47. Sayre L.M., Zelasko D.A., Harris P.L.R., Perry G., Salomon R.G., Smith M.A. 4-Hydroxynonenal-derived advanced lipid peroxidant end products are increased in Alzheimer disease. J. Neurochem. 68:1997;2092-2097.
48. Shimizu S., Eguchi Y., Kamiike W., Matsuda H., Tsujimato Y. Bcl-2 expression prevents activation of the ICE protease cascade. Oncogene. 12:1996;2251-2257.
49. Shimizu S., Eguchi Y., Kamiike W., Waguri S., Uchiyama Y., Matsuda H., Tsujimato Y. Retardation of chemical hypoxia-induced necrotic cell death by Bcl-2 and ICE inhibitors: possible involvement of common mediators in apoptotic and necrotic signal transductions. Oncogene. 12:1996;2045-2050.
50. Shimohama S., Fujimoto S., Matsushima H., Takenawa T., Taniguchi T., Perry G., Whitehouse P.J., Kimura J. Alteration of phospholipase C-δ protein level and specific activity in Alzheimer's disease. J. Neurochem. 64:1995;2629-2634.
51. Shimohama S., Narita M., Matsushima H., Kimura J., Hagiwara M., Hidaka H., Taniguchi T. Assessment of protein kinase C isozymes by two-site enzyme immunoassay in human brains and changes in Alzheimer's disease. Neurology. 43:1993;1407-1413.
52. Shimohama S., Taniguchi T., Fujiwara M., Kameyama M. Changes in nicotinic and muscarinic cholinergic receptors in Alzheimer-type dementia. J. Neurochem. 46:1986;288-293.
53. Shimohama S., Taniguchi T., Fujiwara M., Kameyama M. Biochemical characterization of α-adrenergic receptors in human brain and changes in Alzheimer-type dementia. J. Neurochem. 47:1986;1294-1301.
54. Shimohama S., Taniguchi T., Fujiwara M., Kameyama M. Changes in β-adrenergic receptor subtypes in Alzheimer-type dementia. J. Neurochem. 48:1987;1215-1221.
55. Smale G., Nichols N.R., Brady D.R., Finch C.E., Horton W.E. Jr. Evidence for apoptotic cell death in Alzheimer's disease. Exp. Neurol. 133:1995;225-230.
56. Smith M.A., Harris P.L.R., Sayre L.M., Beckman J.S., Perry G. Widespread peroxynitrite-mediated damage in Alzheimer disease. J. Neurosci. 17:1997;2653-2657.
57. Smith M.A., Perry G., Richey P.L., Sayre L.M., Anderson V.E., Kowall N. Oxidative damage in Alzheimer's. Nature. 382:1996;120-121.
58. Smith M.A., Sayre L.M., Monnier V.M., Perry G. Radical AGEing in Alzheimer's disease. Trends Neurosci. 18:1995;172-176.
59. Smith M.A., Taneda S., Richey P.L., Miyata S., Yan S.-D., Stern D., Sayre I.M., Monnier V.M., Perry G. Advanced Maillard reaction products are associated with Alzheimer disease pathology. Proc. Natl. Acad. Sci. USA. 91:1994;5710-5714.
60. Su J.H., Anderson A.J., Cummings B.J., Cotman C.W. Immunohistochemical evidence for apoptosis in Alzheimer's disease. NeuroReport. 5:1994;2529-2533.
61. Tsang S.Y., Tam S.C., Bremner I., Burkitt M.J. Copper-1,10-phenanthroline induces internucleosomal DNA fragmentation in HepG2 cells, resulting from direct oxidation by the hydroxyl radical. Biochem. J. 317:1996;13-16.
62. Vitek M.P., Bhattacharya K., Glendening J.M., Stopa E., Vlassara H., Bucala R., Manogue K., Cerami A. Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc. Natl. Acad. Sci. USA. 91:1994;4766-4770.
63. Wang L., Miura M., Bergeron L., Zhu H., Yuan J. Ich-1, and Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell. 78:1994;739-750.
64. Wood P.C., Wojcikiewicz R.J.H., Burgess J., Castleden C.M., Nahorski S.R. Aluminium inhibits muscarinic agonist-induced inositol 1,4,5-trisphosphate production and calcium mobilization in permeabilized SH-SY5Y human neuroblastoma cells. J. Neurochem. 62:1994;2219-2223.
65. Yan S.-D., Chen X., Schmidt A.-M., Brett J., Godman G., Zou Y.-S., Scott C.W., Caputo C., Frappier T., Smith M.A., Perry G., Yen S.-H., Stern D. Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress. Proc. Natl. Acad. Sci. USA. 91:1994;7787-7791.
66. Yankner B.A. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron. 16:1996;921-932.
67. L and Bcl-2, displaces Bax and promotes cell death. Cell. 80:1995;285-291.
68. Yin X.-M., Oltvai Z.N., Korsmeyer S.J. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature. 369:1994;321-323.